Evidence map›Paper›PMID 40951362›Full record

ArticleFrontiers in oncology2025

Real-world data on adult AML with

Thanawat Rattanathammethee, Ekarat Rattarittamrong, Chinadol Wanitpongpun, Smith Kungwankiattichai, Weerapat Owattanapanich, Chantiya Chanswangphuwana, Chantana Polprasert, Thanakrit Piyajaroenkij, Pimjai Niparuck, Supawee Saengboon and 10 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Thanawat RattanathammetheeDivision of Hematology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Ekarat RattarittamrongDivision of Hematology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Chinadol WanitpongpunDivision of Hematology, Department of Internal Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Smith KungwankiattichaiDivision of Hematology, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Weerapat OwattanapanichDivision of Hematology, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Chantiya ChanswangphuwanaDivision of Hematology and Center of Excellence in Translational Hematology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Chantana PolprasertDivision of Hematology and Center of Excellence in Translational Hematology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Thanakrit PiyajaroenkijDivision of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Pimjai NiparuckDivision of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Supawee SaengboonDivision of Hematology, Department of Internal Medicine, Thammasat University, Pathumthani, Thailand.
Wasithep LimvorapitakDivision of Hematology, Department of Internal Medicine, Thammasat University, Pathumthani, Thailand.
Panachai SilpsamritDivision of Hematology, Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.
Kannadit PrayongratanaDivision of Hematology, Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.
Chantrapa SriswasdiDivision of Hematology, Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand.
Jakrawadee JulamaneeHematology Unit, Division of Internal Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand.
Pirun SaelueHematology Unit, Division of Internal Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand.
Aimwipa SasakulDivision of Hematology, Department of Medicine, Chulabhorn Hospital, Bangkok, Thailand.
Dusit Jit-UeakulDivision of Hematology, Department of Medicine, Faculty of Medicine, Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand.
Chajchawan NakhakesDivision of Hematology, Department of Medicine, Rajavithi Hospital, Bangkok, Thailand.
Adisak TantiworawitDivision of Hematology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: We analyzed data from 360 adult patients with newly diagnosed AML, prospectively collected from 11 institutions nationwide between 2016 and 2023. Results: Conclusions: In this nationwide real-world study,

Indexed as

acute myeloid leukemiaFLT3-ITD mutationreal-world dataThailandtreatment outcomes

Identifiers

PMID40951362
PMCPMC12425767

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.